Acasti Pharma Inc.

Acasti Announces Fiscal 2013 Results and Provides Update on Status of Clinical Trials

LAVAL, Quebec, May 22, 2013 (GLOBE NEWSWIRE) -- Acasti Pharma ("Acasti" or the "Corporation") (Nasdaq:ACST) (TSX-V:APO), a Neptune Technologies & Bioressources Inc.'s ("Neptune") subsidiary, announces its consolidated financial results for the fourth quarter and fiscal year ended February 28, 2013 and provides an update on the status of its Phase II clinical trials.

Acasti Pharma Inc.

Acasti Pharma Presents Preliminary Data Moving Forward With Clinical Strategy

LAVAL, Quebec, March 19, 2013 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. ("

Acasti Pharma Inc.

Acasti Pharma Reports Its Third Quarter Results

LAVAL, Quebec, Jan. 15, 2013 (GLOBE NEWSWIRE) -- Acasti Pharma ("Acasti" or the "Corporation") (Nasdaq:ACST) (TSX.V:APO), a Neptune Technologies & Bioressources Inc. ("Neptune") subsidiary, reports the highlights of its financial results for the third quarter, ended November 30, 2012.

Acasti Pharma Inc.

Acasti Pharma Shares to Trade on NASDAQ

LAVAL, Quebec, Jan. 7, 2013 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. ("

Acasti Pharma Inc.

Acasti Pharma Provides an Insight of Its Current Clinical Trials Results

LAVAL, Quebec, Dec. 17, 2012 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. ("

Acasti Pharma Inc.

Acasti Pharma Becomes Royalty Free

LAVAL, Quebec, Dec. 4, 2012 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. ("

Acasti Pharma Inc.

Acasti Pharma Provides Update After Explosion at Neptune's Plant

LAVAL, Quebec, Nov. 12, 2012 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. ("

Acasti Pharma Inc.

Acasti Pharma Reports Its Second Quarter Results

LAVAL, Quebec, Oct. 17, 2012 (GLOBE NEWSWIRE) -- Acasti Pharma ("Acasti" or the "Corporation") (TSX.V.APO), a Neptune Technologies & Bioressources Inc. ("Neptune") subsidiary, reports the highlights of its financial results for the second quarter, ended August 31, 2012.

Acasti Pharma Inc.

Acasti Pharma First Quarter Results

LAVAL, Quebec, July 31, 2012 (GLOBE NEWSWIRE) -- Acasti Pharma ("Acasti" or the "Corporation") (TSX.V.APO), a Neptune Technologies & Bioressources Inc's ("Neptune") subsidiary, reports the highlights of its financial results for the first quarter ended May 31, 2012.

Acasti Pharma Inc.

Acasti Pharma to Present at JMP Securities Healthcare Conference

LAVAL, Quebec, July 9, 2012 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. ("Acasti") (TSX-V:APO), a Neptune Technologies & Bioressources Inc. ("Neptune") subsidiary, announces it will present at the 2012 JMP Securities Healthcare Conference: